EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Private board matters
We support private board of directors members by providing insights, tools and analysis on the issues and trends impacting their business.
Our latest thinking
How board committee responsibilities and structures are changing
Find out how board committee structures and responsibilities are evolving.
How boards can champion a resilient talent strategy
We highlight four opportunities for boards to champion a resilient talent strategy.
How founder CEOs can evolve their board and scale their business
By taking a strategic approach to the board search process, founder CEOs can find talented board candidates who can help scale the company. Learn more.
Four ways boards can support the effective use of AI
Find out four ways boards can enhance their oversight of AI to create operating efficiencies and support strategy and growth.
How private boards unlock value by elevating risk management
Private boards can unlock value by elevating risk management. Learn more.
What founders should know about board service
By thinking and preparing strategically, founders can differentiate themselves and secure a board appointment. Learn more.
Americas board priorities 2024
Find out what board members in the Americas consider to be top priorities for 2024.
What audit committees should prioritize in 2024
We highlight audit committee priorities for 2024 and address key risk management, financial reporting, tax and the regulatory developments.
Eight AI-related US policy issues for boards and management to consider
As the use of AI evolves, boards and the C-suite should consider these key AI-related issues attracting US policymaker attention.
What cyber disclosures are telling shareholders in 2023
Find out what we learned from an analysis of cyber‑related disclosures of Fortune 100 companies over the past six years.